caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1992728323

Jill KerekesM.D.

PRACTICEMAINEHEALTHSee all providers at this practice →
Internal MedicineWindham, MEI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
5,064
Beneficiaries
—
Total drug cost
$377K
Distinct drugs
102
Brand share
21.8%
Top prescribed drugs
Atorvastatin Calcium331 claims
Lisinopril232 claims
Omeprazole230 claims
Levothyroxine Sodium213 claims
Amlodipine Besylate189 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
169
Unique beneficiaries
—
Total services
207
Distinct HCPCS
3
Medicare payment
$9K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 404 Internal Medicine providers in ME — below median (cohort median 401).
REFERRAL NETWORK

Where Jill Kerekes's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
MAINEHEALTH159753
MAINE MEDICAL PARTNERS130637
Nordx
Clinical Laboratory · Scarborough, ME
93658
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.